Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02616965
Title A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Fox Chase Cancer Center

anaplastic large cell lymphoma

mycosis fungoides

Sezary's disease

cutaneous T cell lymphoma


Brentuximab vedotin + Romidepsin

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.